UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

The Journal of experimental medicine, 2018-01, Vol.215 (1), p.141-157

2018

Volltextzugriff (PDF)

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1425-1437

2017

Volltextzugriff (PDF)

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

Journal of neuro-oncology, 2016-12, Vol.130 (3), p.543-552

2016

Volltextzugriff (PDF)

Characterizing the Microvascular Phenotype of Mouse Models of Glioblastoma and Anaplastic Thyroid Cancer

Shrivastav, Shruti

2019

Volltextzugriff (PDF)

IMST-14. IDH1 R132H MUTATION INHIBITS ANTI-GLIOMA IMMUNE RESPONSES THROUGH POST-TRANSCRIPTIONAL DOWN-REGULATION OF STAT1 AND TYPE-1 CHEMOKINES

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi88-vi88

2016

Volltextzugriff (PDF)

IMMU-42. ONO-AE3-208 PROMOTES ANTI-TUMOR IMMUNE ACTIVITY AND SURVIVAL IN GLIOMA MODELS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi122-vi122

2017

Volltextzugriff (PDF)

Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3767-3767

2017

Volltextzugriff (PDF)

Isocitrate dehydrogenase mutations suppress STAT1 and CD8 super( +) T cell accumulation in gliomas

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1425-1425

2017

Volltextzugriff (PDF)

Isocitrate dehydrogenase mutations suppress STAT1 and [CD8.sup.+] T cell accumulation in gliomas

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1425

2017

Volltextzugriff (PDF)

Isocitrate dehydrogenase mutations suppress STAT1 and CD8^sup +^ T cell accumulation in gliomas

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1425

2017

Volltextzugriff (PDF)

Reverse phase protein microarray for identification of IL6 receptor ligation-induced insulin receptor, PI3K/AKT, and JAK/STAT signaling pathways in the CARD11 mutated lymphoma cell line OCI-Ly3

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8574-8574

2014

Volltextzugriff (PDF)

IMST-09. IDENTIFICATION OF A NOVEL H3.3.K27M MUTATION-DERIVED NEOANTIGEN EPITOPE AND CLONING OF A SPECIFIC T-CELL RECEPTOR FOR T-CELL THERAPY IN GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi87-vi87

2016

Volltextzugriff (PDF)

IMMU-41. H3.3K27M MUTATION-DERIVED NOVEL NEOANTIGEN – CHARACTERIZATION OF THE HLA-A2-BINDING EPITOPE AND A SPECIFIC T CELL RECEPTOR FOR DEVELOPMENT OF T CELL-BASED IMMUNOTHERAPY

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi121-vi121

2017

Volltextzugriff (PDF)

HG-81NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii67.1-iii67

2016

Volltextzugriff (PDF)

IMPS-30NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v119.4-v119

2015

Volltextzugriff (PDF)

MTR-01BEVACIZUMAB-INDUCED MIF DEPLETION: A NOVEL RESISTANCE MECHANISM IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v124.1-v124

2015

Volltextzugriff (PDF)

IDH mutation-induced suppression of type-1 anti-glioma immune response

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P271-P271, Article P271

2015

Volltextzugriff (PDF)

Abstract A117: Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.A117-A117

2016

Volltextzugriff (PDF)

Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P445-P445

2015

Volltextzugriff (PDF)

Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19

Lab on a chip, 2020-06, Vol.2 (12), p.275-285

2020

Volltextzugriff (PDF)

Novel Bismuth Sulfide-Indium (Hydroxy) Sulfide [Bi2S3–In(OH)xSy] nanoarchitecture for efficient photoelectrochemical water splitting

Journal of power sources, 2023-07, Vol.571, p.233084, Article 233084

2023

Volltextzugriff (PDF)

Debonding Techniques - A Review

Journal of evolution of medical and dental sciences, 2021-09, Vol.10 (38), p.3430-3435

2021

Volltextzugriff (PDF)

Artificial Intelligence and Computational Dynamics for Biomedical Research

Ankur Saxena, Nicolas Brault / Ankur Saxena, Nicolas Brault

2022

Volltextzugriff (PDF)

Comparative Evaluation of Discomfort, Expectations and Functional Experiences during Treatment of Class II Malocclusion with Forsus Fixed Functional Appliance and Sharma’s Class II Corrector - A Questionnaire Based Survey

Journal of evolution of medical and dental sciences, 2021-02, Vol.10 (8), p.474-478

2021

Volltextzugriff (PDF)

Anti-Diabetic potential of a polyherbal formulation-A review

Research journal of pharmacy and technology, 2018-06, Vol.11 (6), p.2625-2630

2018

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(5)
Care And Treatment
(4)
Immunotherapy
(4)
Life Sciences & Biomedicine
(4)
Lymphocytes
(4)
Mutation
(4)
Abstracts
(3)
Animals
(3)
Development And Progression
(3)
Genetic Aspects
(3)
Gliomas
(3)
Health Aspects
(3)
Humans
(3)
Medicine
(3)
Abstracts From The 20th Annual Scientific Meeting Of The Society For Neuro-Oncology
(2)
Albinism
(2)
Antidiabetics
(2)
Antihyperglycemic
(2)
Brain Cancer
(2)
Chemistry
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

Characterizing the Microvascular Phenotype of Mouse Models of Glioblastoma and Anaplastic Thyroid Cancer

IMST-14. IDH1 R132H MUTATION INHIBITS ANTI-GLIOMA IMMUNE RESPONSES THROUGH POST-TRANSCRIPTIONAL DOWN-REGULATION OF STAT1 AND TYPE-1 CHEMOKINES

IMMU-42. ONO-AE3-208 PROMOTES ANTI-TUMOR IMMUNE ACTIVITY AND SURVIVAL IN GLIOMA MODELS

Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma

Isocitrate dehydrogenase mutations suppress STAT1 and CD8 super( +) T cell accumulation in gliomas

Isocitrate dehydrogenase mutations suppress STAT1 and [CD8.sup.+] T cell accumulation in gliomas

Isocitrate dehydrogenase mutations suppress STAT1 and CD8^sup +^ T cell accumulation in gliomas

Reverse phase protein microarray for identification of IL6 receptor ligation-induced insulin receptor, PI3K/AKT, and JAK/STAT signaling pathways in the CARD11 mutated lymphoma cell line OCI-Ly3

IMST-09. IDENTIFICATION OF A NOVEL H3.3.K27M MUTATION-DERIVED NEOANTIGEN EPITOPE AND CLONING OF A SPECIFIC T-CELL RECEPTOR FOR T-CELL THERAPY IN GLIOMAS

IMMU-41. H3.3K27M MUTATION-DERIVED NOVEL NEOANTIGEN – CHARACTERIZATION OF THE HLA-A2-BINDING EPITOPE AND A SPECIFIC T CELL RECEPTOR FOR DEVELOPMENT OF T CELL-BASED IMMUNOTHERAPY

HG-81NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION

IMPS-30NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION

MTR-01BEVACIZUMAB-INDUCED MIF DEPLETION: A NOVEL RESISTANCE MECHANISM IN GLIOBLASTOMA

IDH mutation-induced suppression of type-1 anti-glioma immune response

Abstract A117: Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation

Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19

Novel Bismuth Sulfide-Indium (Hydroxy) Sulfide [Bi2S3–In(OH)xSy] nanoarchitecture for efficient photoelectrochemical water splitting

Debonding Techniques - A Review

Artificial Intelligence and Computational Dynamics for Biomedical Research

Comparative Evaluation of Discomfort, Expectations and Functional Experiences during Treatment of Class II Malocclusion with Forsus Fixed Functional Appliance and Sharma’s Class II Corrector - A Questionnaire Based Survey

Anti-Diabetic potential of a polyherbal formulation-A review

Suchergebnisse filtern